20 results
8-K
EX-99.1
NEXI
Neximmune Inc
18 Oct 23
NexImmune Announces 1-for-25 Reverse Stock Split
4:15pm
on the Nasdaq Capital Market; the impact of our workforce reduction; the enrollment, timing, progress, release of data from and results of the Company’s paused
8-K
lwmbnpta12y g35
31 Aug 23
Cost Associated with Exit or Disposal Activities
5:11pm
8-K
yir6jn
14 Nov 22
NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update
4:11pm
8-K
EX-99.1
r60bw
14 Nov 22
NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update
4:11pm
10-K
p8uz7kvo vnrbxq41
31 Mar 21
Annual report
4:02pm
424B4
dmj7ayfhxoo8dcawadao
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
iya19v0e f773jo
8 Feb 21
IPO registration (amended)
7:29am
S-1
xy4d 6m429
19 Jan 21
IPO registration
4:38pm
DRS/A
dz2rh42na dtwwowpula
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
wz93n5
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next